BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10064401)

  • 21. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
    Labonte S; Hanna W; Bandarchi-Chamkhaleh B
    J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatofibrosarcoma protuberans recurring as a giant cell fibroblastoma with subsequent fibrosarcomatous change.
    Pitt MA; Coyne JD; Harris M; McWilliam LJ
    Histopathology; 1994 Feb; 24(2):197-8. PubMed ID: 8181817
    [No Abstract]   [Full Text] [Related]  

  • 23. [Giant cell fibroblastoma recurring as dermatofibrosarcoma. A pediatric case report].
    Cherradi N; Malihy A; Benkiran L; Barahioui M; Alhamany Z
    Ann Pathol; 2002 Dec; 22(6):465-8. PubMed ID: 12594389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous dermatofibrosarcoma protuberans in skin of the breast: may mimic a primary breast lesion.
    Bulliard C; Murali R; Chang LY; Brennan ME; French J
    Pathology; 2007 Aug; 39(4):446-8. PubMed ID: 17676490
    [No Abstract]   [Full Text] [Related]  

  • 25. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant.
    Diaz-Cascajo C
    J Cutan Pathol; 1997 Mar; 24(3):197-8. PubMed ID: 9085158
    [No Abstract]   [Full Text] [Related]  

  • 26. Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature.
    Ghorbani RP; Malpica A; Ayala AG
    Int J Gynecol Pathol; 1999 Oct; 18(4):366-73. PubMed ID: 10542946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic and immunohistochemical evidence that giant cell fibroblastoma is related to dermatofibrosarcoma protuberans.
    Dal Cin P; Sciot R; de Wever I; Brock P; Casteels-Van Daele M; Van Damme B; Van Den Berghe H
    Genes Chromosomes Cancer; 1996 Jan; 15(1):73-5. PubMed ID: 8824728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and pathological changes in a long-term follow-up case of dermatofibrosarcoma protuberans.
    Yamamoto Y; Toyozawa S; Uede K; Oda Y; Nakamura Y; Furukawa F
    J Dermatol; 2011 Feb; 38(2):203-5. PubMed ID: 21269323
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD34-positive myxoid dermatofibrohistiocytoma of the skin: an indolent post-traumatic tumor that can be mistaken for dermatofibrosarcoma protuberans.
    Al-Quran SZ; Russo JJ; Bandarchi-Chamkhaleh B; Hassanein AM
    J Cutan Pathol; 2009 Jan; 36(1):84-6. PubMed ID: 19125740
    [No Abstract]   [Full Text] [Related]  

  • 32. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis.
    Sabater-Marco V; Pérez-Vallés A; Berzal-Cantalejo F; Rodriguez-Serna M; Martinez-Diaz F; Martorell-Cebollada M
    Int J Dermatol; 2006 Jan; 45(1):59-62. PubMed ID: 16426380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: 10 years' experience in a tertiary hospital.
    Lo CH; Tsang PM; Cheng SY
    Autops Case Rep; 2022; 12():e2021368. PubMed ID: 35496732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dermatofibrosarcoma protuberans : report of 27 cases and review of the literature].
    Hammas N; Badioui I; Znati K; Benlemlih A; Chbani L; El Fatemi H; Harmouch T; Bouyahyaoui Y; Boutayeb F; Mrini A; Mesbahi O; Mernissi FZ; Amarti A
    Pan Afr Med J; 2014; 18():280. PubMed ID: 25489374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatofibrosarcoma protuberans in childhood and adolescence: report of eight patients.
    Jafarian F; McCuaig C; Kokta V; Laberge L; Ben Nejma B
    Pediatr Dermatol; 2008; 25(3):317-25. PubMed ID: 18577035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate.
    Thomison J; McCarter M; McClain D; Golitz LE; Goldenberg G
    J Cutan Pathol; 2008 Nov; 35(11):1003-6. PubMed ID: 18544062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Darier-White disease and dermatofibrosarcoma protuberans.
    Loche F; Carrière M; Schwarze HP; Thédenat B; Bazex J
    Dermatology; 1999; 199(3):279. PubMed ID: 10592418
    [No Abstract]   [Full Text] [Related]  

  • 40. Congenital atrophic dermatofibrosarcoma protuberans.
    Marini M; Saponaro A; Magariños G; de Baldrich A; Lynch P; Remorino L
    Int J Dermatol; 2001 Jul; 40(7):448-50. PubMed ID: 11679000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.